Trade Names: | |
Synonyms: | |
Status: | Approved (1977) |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | C10AX02 |
UNII: | P3CTH044XJ |
InChI Key | FYPMFJGVHOHGLL-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C31H48O2S2 |
Molecular Weight | 516.86 |
AlogP | 9.91 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 40.46 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 35.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | ATP-binding cassette sub-family A member 1 inhibitor | PubMed |
Primary Target | |
---|---|
ABCA1 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | 14000 | - | - | 27-37 | |
Enzyme
Transferase
|
- | - | - | - | 29 | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class III
|
- | 1600 | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 102 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hyperlipidemias | 3 | D006949 | ClinicalTrials |
Diabetic Nephropathies | 2 | D003928 | ClinicalTrials |
Peripheral Arterial Disease | 2 | D058729 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 23288-49-5 |
ChEBI | 8427 |
ChEMBL | CHEMBL608 |
DrugBank | DB01599 |
DrugCentral | 2269 |
EPA CompTox | DTXSID2045440 |
FDA SRS | P3CTH044XJ |
Human Metabolome Database | HMDB0015537 |
Guide to Pharmacology | 7277 |
KEGG | C07373 |
PharmGKB | PA451107 |
PubChem | 4912 |
SureChEMBL | SCHEMBL4150 |
ZINC | ZINC000001530755 |